✨ Free AI Report
Nascent Pharma Holdings, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Nascent Pharma Holdings, Inc.
Company Research

Nascent Pharma Holdings, Inc.: Business Overview, Financials & Competitive Analysis

The company was formerly known as Can B Corp. and changed its name to Nascent Pharma Holdings, Inc. in September 2025. The company is a forward-thinking pharmaceutical Intellectual Property company focused on maximizi...

Analyst-debate audio for Nascent Pharma Holdings, Inc.

AskCyborg analysts argue the bull and bear cases for Nascent Pharma Holdings, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
2/ 10Challenged

Cyborg Score thesis

Micro-cap IP holder betting on cannabis patent portfolio value with severely declining revenue and persistent...

Read the full analyst-debate transcript →
Industry Cannabis
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 7, 2026
AI-Verified Research
30+ Page Report

Get the Latest Nascent Pharma Holdings, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Nascent Pharma Holdings, Inc. Overview

Pro stress-test →

The company was formerly known as Can B Corp. and changed its name to Nascent Pharma Holdings, Inc. in September 2025. The company is a forward-thinking pharmaceutical Intellectual Property company focused on maximizing the value of its cannabis patent portfolios. It also produces superfood drink mix products under the Longevity brand name.

Strategic Profile

Pro stress-test →

Nascent Pharma Holdings is focused on maximizing the value of its cannabis patent portfolios, with patents valued at $122,000,000 in 2020 by an independent valuation firm. The name and symbol change follow the holding company reorganization completed in October 2024. The company operates as a penny stock on OTC markets with minimal current revenue and significant operating losses.

Competitive Landscape

Pro stress-test →

Can B Corp's top competitors include Exhemplary Life, Better Health First, Gruene Botanicals, and Green Market. The company operates in a highly fragmented hemp and CBD products market competing against established wellness brands and larger pharmaceutical companies pursuing cannabis-derived therapeutics.

Industry Context

Nascent Pharma Holdings, Inc. operates in Cannabis.

Key facts

Founded: 2005 · Headquarters: Hicksville, NY, United States · Employees: 12 · Revenue: $2.16M (2023) · Market cap: $1.92M

What the analysts stress-tested

The top findings that survived the multi-agent debate for Nascent Pharma Holdings, Inc..

  • Patented uses include treating cancer, IBS, chronic pain, PTSD, anxiety, sleep disorders, and opioid dependencies; the company plans to pursue opportunities to license and develop uses for these patents.
  • Revenue collapsed 67.76% year-over-year in 2023 to $2.16M while losses reached $9.74M, indicating severe operational challenges.
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • September 2025Completed name change from Can B Corp. to Nascent Pharma Holdings, Inc. and ticker change to NASC
  • October 2024Completed holding company reorganization with Nascent Pharma Holdings becoming parent company
  • +1 moreTrack every material event for Nascent Pharma Holdings, Inc. as it happens. Explore monitoring →
Get alerted when Nascent Pharma Holdings, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Exhemplary LifeHemp and CBD wellness products→Better Health FirstHealth and wellness products→Gruene BotanicalsBotanical wellness products→

Compare Nascent Pharma Holdings, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Nascent Pharma Holdings, Inc. operates in Cannabis. See how the rest of the sector scores on the Cyborg framework.

Browse Cannabis research →
NEW · MCP server

Ask your AI assistant about Nascent Pharma Holdings, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Nascent Pharma Holdings, Inc. and its top competitor on Cyborg Score”
“What did Nascent Pharma Holdings, Inc. do this quarter?”
“Is Nascent Pharma Holdings, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Nascent Pharma Holdings, Inc. do?+
The company was formerly known as Can B Corp. and changed its name to Nascent Pharma Holdings, Inc. in September 2025. The company is a forward-thinking pharmaceutical Intellectual Property company focused on maximizi...
What is Nascent Pharma Holdings, Inc.'s Cyborg Score?+
Nascent Pharma Holdings, Inc. has a Cyborg Score of 2/10 (Challenged). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Nascent Pharma Holdings, Inc.'s main competitors?+
Named competitors include Exhemplary Life, Better Health First, Gruene Botanicals. The full competitive landscape is in the AskCyborg report.
How can I get the full Nascent Pharma Holdings, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Nascent Pharma Holdings, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Nascent Pharma Holdings, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Cannabis research

Companies in the same sector and named competitors, ranked by Cyborg Score.

7Cronos Group Inc.6Ayr Wellness